Generic semaglutide launches in India on the day the core patent expires

Indian drugmakers including Dr Reddy's, Sun Pharma, Glenmark, Zydus and Alkem launched generic semaglutide injections on March 21, 2026, as soon as Novo Nordisk's core Indian patent expired. Prices ranged from about INR 325 to 440 a week for the cheapest brand to about INR 4,200 a month for a prefilled pen. The launches made India one of the first large markets with generic semaglutide.